UC San Francisco Cell Therapy Raises Hope for Severe Human Forms
Epilepsy that does not respond to drugs can be halted in adult mice by transplanting a specific type of cell into the brain, UC San Francisco researchers have discovered, raising hope that a similar treatment might work in severe forms of human epilepsy.
UCSF scientists controlled seizures in epileptic mice with a one-time transplantation of medial ganglionic eminence (MGE) cells, which inhibit signaling in overactive nerve circuits, into the hippocampus, a brain region associated with seizures, as well as with learning and memory. Other researchers had previously used different cell types in rodent cell transplantation experiments and failed to stop seizures.
Cell therapy has become an active focus of epilepsy research, in part because current medications, even when effective, only control symptoms and not underlying causes of the disease, according to Scott C. Baraban, PhD, who holds the William K. Bowes Jr. Endowed Chair in Neuroscience Research at UCSF and led the new study. In many types of epilepsy, he said, current drugs have no therapeutic value at all.
“Our results are an encouraging step toward using inhibitory neurons for cell transplantation in adults with severe forms of epilepsy,” Baraban said. “This procedure offers the possibility of controlling seizures and rescuing cognitive deficits in these patients.”
The findings, which are the first ever to report stopping seizures in mouse models of adult human epilepsy, will be published online May 5 in the journal Nature Neuroscience.
During epileptic seizures, extreme muscle contractions and, often, a loss of consciousness can cause seizure sufferers to lose control, fall and sometimes be seriously injured. The unseen malfunction behind these effects is the abnormal firing of many excitatory nerve cells in the brain at the same time.
In the UCSF study, the transplanted inhibitory cells quenched this synchronous, nerve-signaling firestorm, eliminating seizures in half of the treated mice and dramatically reducing the number of spontaneous seizures in the rest. Robert Hunt, PhD, a postdoctoral fellow in the Baraban lab, guided many of the key experiments.
In another encouraging step, UCSF researchers reported May 2 that they found a way to reliably generate human MGE-like cells in the laboratory, and that, when transplanted into healthy mice,the cells similarly spun off functional inhibitory nerve cells. That research can be found online in the journal Cell Stem Cell.
In many forms of epilepsy, loss or malfunction of inhibitory nerve cells within the hippocampus plays a critical role. MGE cells are progenitor cells that form early within the embryo and are capable of generating mature inhibitory nerve cells called interneurons. In the Baraban-led UCSF study, the transplanted MGE cells from mouse embryos migrated and generated interneurons, in effect replacing the cells that fail in epilepsy. The new cells integrated into existing neural circuits in the mice, the researchers found.
“These cells migrate widely and integrate into the adult brain as new inhibitory neurons,” Baraban said. “This is the first report in a mouse model of adult epilepsy in which mice that already were having seizures stopped having seizures after treatment.”
The mouse model of disease that Baraban’s lab team worked with is meant to resemble a severe and typically drug-resistant form of human epilepsy called mesial temporal lobe epilepsy, in which seizures are thought to arise in the hippocampus. In contrast to transplants into the hippocampus, transplants into the amygdala, a brain region involved in memory and emotion, failed to halt seizure activity in this same mouse model, the researcher found.
The Latest Bing News on:
Epilepsy
- Hidden Brain Region May Unlock New Epilepsy Treatmenton April 19, 2024 at 8:55 am
A new study offers an explanation and suggests a more effective approach to treatment of epilepsy. They found a previously overlooked region of the hippocampus, the fasciola cinereum, appears to be ...
- Epilepsy patients for adequate drugson April 19, 2024 at 12:49 am
According to World Health Organisation (WHO), 25 percent of Epilepsy cases are preventable with certain criteria such as preventing head injury, taking adequate perinatal care and avoiding drug use ...
- Epilepsy procedure helping South Florida teen improve quality of lifeon April 18, 2024 at 6:46 pm
An epilepsy diagnosis affects one in every 26 people. Jose Saenz was diagnosed with epilepsy as a child. Now a teenager, he has a new medical device that helps him manage his seizures and improve his ...
- Annual ‘Walk the Talk for Epilepsy’ to be held Apr. 20on April 18, 2024 at 1:58 pm
Hosted by Epilepsy Alliance Florida, the annual Walk the Talk for Epilepsy is the largest community event in the area that raises awareness and funds for people living with the neurological disease.
- Hemorrhagic complications rare after cranial epilepsy surgeryon April 18, 2024 at 1:09 pm
Hemorrhagic complications are uncommon after cranial epilepsy surgery, according to a study published online April 12 in World Neurosurgery.
- Harvard Health Publishing And 3 More Doctors Weigh In On: What Can Trigger Epilepsy?on April 17, 2024 at 2:28 pm
Answered by Dr. Howard E. Lewine M.D. Chief Medical Editor, Harvard Health Publishing · 40 years of experience · USA Many conditions can affect the brain and trigger a seizure, including:, Brain ...
- Surgery targeting brain region may relieve tough-to-treat epilepsyon April 17, 2024 at 10:05 am
Some people with tough-to-treat epilepsy might benefit if doctors target a brain region newly linked to the disorder, a new study suggests.
- O2 confirms its advert has passed photosensitive epilepsy safety testson April 17, 2024 at 5:00 am
We reached out to mobile network O2 this week after a number of people with epilepsy contacted us with concerns about strobe lighting in its recent advert.
- Annual Epilepsy Foundation Walk raises funds, awarenesson April 17, 2024 at 2:31 am
With this event, the foundation raised funding for the West Texas area to make resources available to those with epilepsy at no cost.
- My wife lost licence due to epilepsy and had a stroke and my son needs surgery.. snooker’s taken a backseat, says Wilsonon April 16, 2024 at 10:32 am
KYREN WILSON has spoken for the first time about the family turmoil that has impacted his Crucible preparations. The Warrior, 32, heads into the flagship event as the 12th seed and with memories ...
The Latest Google Headlines on:
Epilepsy
[google_news title=”” keyword=”Epilepsy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Cell therapy
- CAR-T cell therapy gains momentum as future of cancer care in Indiaon April 19, 2024 at 7:30 pm
CAR-T cell therapy gains momentum as future of cancer care in India: Nandita Vijayasimha, Bengaluru Saturday, April 20, 2024, 08:00 Hrs [IST] CAR-T cell therapy in oncology is gai ...
- CAR-T cell therapy could improve kidney transplantson April 19, 2024 at 3:32 pm
Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) could provide a revolutionary approach to organ transplantation for patients who are hard to match and susceptible to rejection, Mayo ...
- Cellares unveils first-of-its-kind cell therapy manufacturing toolon April 19, 2024 at 10:47 am
Cellares unveiled Cell Q Thursday, the first automated quality control (QC) workcell for cell therapy manufacturing. According to the company, Cell Q complements its Cell Shuttle Platform by ...
- SCG Cell Therapy and A*STAR Collaborate on Scalable GMP Manufacturing of Cellular Immunotherapieson April 18, 2024 at 7:00 pm
SCG says it has developed in-house cGMP manufacturing capabilities to supply high-quality cell therapy products to patients.
- Shinobi strikes deal with electronics powerhouse Panasonic to create new cell therapy manufacturing platformon April 18, 2024 at 1:01 pm
History is coming full circle as induced pluripotent stem (iPS) cell-derived cell therapy maker Shinobi Therapeutics links up with Panasonic and Japan’s Kyoto University, where the first mouse iPS | ...
- Novel cell therapy treatments offer promise to immune-compromised childrenon April 18, 2024 at 10:03 am
In a first-of-its-kind clinical trial, researchers found that intravenous therapies made from virus-specific T-cells (VST) can effectively treat immunocompromised pediatric patients, far surpassing ...
- Immunotherapy Regenerative Medicine Clinic on Using Stem Cells to Activate the Body's Natural Healing Poweron April 18, 2024 at 10:02 am
Stem cell therapy, a cornerstone of regenerative medicine, has shown immense potential in treating autoimmune diseases, aging conditions, and ...
- 5x Classic Physique Champion Chris Bumstead Reveals the Effects of Stem Cell Therapy on His Injurieson April 16, 2024 at 8:30 am
Stem Cell therapy is all the rage among athletes, and more bodybuilders are turning to the experimental treatment. Although still not approved around the world, bodybuilders like Chris Bumstead have ...
- Genentech axes Adaptimmune cell therapy deal as it presses ahead with staff cutson April 12, 2024 at 8:22 am
For Adaptimmune, the termination comes almost exactly one year after another pharma discontinued work with the biotech. In April 2023, GSK paid Adaptimmune $37.3 million to wipe its hands of two ...
- Promising Results from Stem Cell Transplant Trial for Spinal Cord Injury Patientson April 10, 2024 at 5:49 pm
A trial involving an experimental stem cell injection therapy for individuals with traumatic spinal cord injury has made encouraging strides in its initial phase I clinical trial. Researchers at the ...
The Latest Google Headlines on:
Cell therapy
[google_news title=”” keyword=”Cell therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]